Improving the identification and validation of disease-specific drug targets in a cell-type and patient-specific manner early on will not only reduce the failure rate and cost that is so inherent in current drug development processes but also allow the development of more effective precision medicines, improving patient outcomes. The post The Future of Drug Discovery…
The real change with AI will happen not when everyone adopts the technology, which is happening quickly, but when these AIs can actually communicate and coordinate with one another. The post The AI Drug Discovery Boom Is Coming. We Are Not Ready. appeared first on MedCity News.
More than 4 million Highmark commercial members now have access to AppliedVR’s RelieVRx as a covered therapeutic. The post Highmark Covers AppliedVR’s Product for Chronic Low Back Pain appeared first on MedCity News.
ViVE’s leaders predict major health IT breakthroughs on the horizon
White bagging not only creates significant uncompensated administrative burden and scheduling challenges for providers, but it also delays or limits access to necessary medication for patients. The post White Bagging: A Prescription for Disruption in Care appeared first on MedCity News.
PHILADELPHIA — Leon Harris, de 35 años, conoce por experiencia personal la devastación que puede causar un arma. Hace casi dos décadas, unos ladrones le dispararon por la espalda, dejándolo paralizado del pecho hacia abajo. La bala aún permanece alojada en su columna. “Cuando te disparan, dejas de pensar en el futuro”, dijo. Su esposa,…
David Oakley, AdventHealth’s chief digital officer, said AI could transform healthcare personalization — moving from broad population segments to individualized “segments of one.” In the future, providers could use connected data platforms to better understand patients’ clinical, social and emotional needs, which has potential to strengthen both trust and engagement, he stated. The post AI…
This brief provides an overview of the Medicare Advantage plans that are available for 2026 and key trends over time. In 2026, the average Medicare beneficiary has a choice of 32 Medicare Advantage prescription drug (MA-PD) plans, two fewer than the 34 in 2025. Virtually all Medicare Advantage plans for 2026 provide multiple extra benefits…
Colton George, un niño de 9 años, de Indiana, se sintió enfermo. Les dijo a sus padres que le dolía el estómago. No paraba de correr al baño y se sentía demasiado mal como para terminar un partido de baloncesto. Días más tarde, estaba en una cama de hospital, luchando por su vida. La demanda…
We’ve seen how transformative innovation can be when supported by focused investment. But if we want to continue advancing healthcare in meaningful ways, we must expand our lens and invest in the spaces that have been left behind. The post Breaking the Cycle: Unlocking the Untapped Opportunities in Healthcare Innovation appeared first on MedCity News.